A detailed history of Metis Global Partners, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 6,219 shares of WST stock, worth $2.08 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,219
Previous 5,719 8.74%
Holding current value
$2.08 Million
Previous $1.88 Million 0.9%
% of portfolio
0.06%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$277.16 - $333.3 $138,580 - $166,650
500 Added 8.74%
6,219 $1.87 Million
Q2 2024

Aug 06, 2024

BUY
$314.68 - $395.94 $68,914 - $86,710
219 Added 3.98%
5,719 $1.88 Million
Q1 2024

May 06, 2024

BUY
$338.27 - $413.0 $22,325 - $27,258
66 Added 1.21%
5,500 $2.18 Million
Q4 2023

Feb 06, 2024

BUY
$318.29 - $392.21 $43,924 - $54,124
138 Added 2.61%
5,434 $1.91 Million
Q3 2023

Nov 07, 2023

BUY
$354.9 - $412.41 $150,832 - $175,274
425 Added 8.73%
5,296 $1.99 Million
Q2 2023

Aug 07, 2023

BUY
$334.63 - $382.47 $191,073 - $218,390
571 Added 13.28%
4,871 $1.86 Million
Q1 2023

May 08, 2023

SELL
$232.5 - $346.47 $16,740 - $24,945
-72 Reduced 1.65%
4,300 $1.49 Million
Q4 2022

Feb 07, 2023

BUY
$209.34 - $261.61 $448,824 - $560,891
2,144 Added 96.23%
4,372 $1.03 Million
Q3 2022

Nov 08, 2022

BUY
$246.08 - $343.65 $130,176 - $181,790
529 Added 31.14%
2,228 $549,000
Q2 2022

Aug 08, 2022

BUY
$280.61 - $420.45 $147,600 - $221,156
526 Added 44.84%
1,699 $513,000
Q1 2022

May 03, 2022

BUY
$357.49 - $445.92 $188,397 - $234,999
527 Added 81.58%
1,173 $482,000
Q4 2021

Feb 11, 2022

BUY
$402.25 - $471.34 $259,853 - $304,485
646 New
646 $303,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.